What Is UDI and Will It Be Mandatory in India? — What Medical Device Importers Need to Know in 2026  

If you are importing medical devices into India, you have probably started hearing more about UDI — Unique Device Identification. And in 2026, you should be paying close attention.

India’s UDI framework already exists on paper — embedded in Rule 46 of the Medical Devices Rules, 2017. What has been missing is an effective implementation date. That ambiguity is narrowing. The regulatory direction from CDSCO is clear: UDI is coming to India, and the global momentum behind it and the global momentum behind it indicates that UDI implementation is expected in the future — and the key question is how prepared you will be when it arrives.

This guide gives medical device importers a complete, factually accurate picture of what UDI is, where India’s implementation currently stands, what the rest of the world has already done, and what you should be doing right now.

What Is UDI (Unique Device Identification)?  

A Unique Device Identifier (UDI) is a globally standardized system that assigns a unique code to each medical device, enabling it to be identified and traced throughout its entire lifecycle — from the manufacturer to the patient.

The UDI consists of two parts:

These two identifiers together create the complete UDI. The code is applied to the device label in both:

• Human Readable Interpretation (HRI) — printed text that can be read directly
• Automatic Identification and Data Capture (AIDC) — barcode (1D or 2D/QR code) that can be scanned by systems

The main regulatory goal of the UDI system is to improve patient safety by enabling precise traceability, faster recalls, reduced medical errors, and better post-market surveillance — benefiting manufacturers, regulatory authorities, healthcare professionals, and patients.

Key distinction: UDI is not just a barcode requirement. It is a complete traceability ecosystem — connecting device labels, databases, supply chain records, clinical usage, and adverse event reporting into a single, coherent identification system.

Why UDI Matters — Specific Benefits for Importers  

For medical device importers specifically, UDI delivers value across multiple dimensions:

Supply Chain Transparency  

Track every device from manufacturer to end-user — knowing exactly where each unit is at any point in the distribution chain.

Faster Recall Management  

In the event of a device recall, UDI allows rapid identification of affected batches and precise, targeted recall communication — reducing patient risk and your liability exposure.

Counterfeit Prevention  

Unique identifiers make counterfeit devices significantly harder to introduce into the supply chain — protecting both patients and your brand reputation.

Post-Market Surveillance  

UDI enables more accurate adverse event reporting — linking specific device batches to clinical outcomes, supporting both CDSCO compliance and quality management.

Implant Traceability  

For implantable devices, UDI ensures that patient records accurately capture which specific device was implanted — critical for long-term patient safety and regulatory compliance.

Global Market Alignment  

If your device is already UDI-compliant for US FDA, EU MDR, or other markets, preparing for India’s eventual mandatory implementation becomes significantly easier.

India’s UDI Status: Where Things Actually Stand in 2026  

This is where accurate information matters most — because several misconceptions circulate about India’s UDI position.

The Legal Framework Already Exists  

Rule 46 of the Medical Devices Rules, 2017 already provides for UDI requirements in India. The original Rule 46 was set to require UDI labeling on medical devices approved for manufacture, sale, distribution, or import by January 1, 2022.

Implementation Was Officially Delayed  

On December 31, 2021, the Indian Ministry of Health and Family Welfare issued a final notification amending Rule 46 of MDR 2017 — delaying the implementation of UDI requirements in India until further guidance is provided. A new timeline was to be specified by MOHFW in the future, along with guidance on how the UDI number must be displayed and what information it must contain.

As of early 2026, no new mandatory implementation date has been officially announced.

What This Means in Plain Terms  

The honest assessment: India’s UDI is not fully mandatory today — but the framework is in place, the delay was formal (not a cancellation), and CDSCO is systematically building the digital compliance infrastructure that UDI requires. Importers who treat this as indefinitely postponed are taking a strategic risk.

Global UDI Status: What the Rest of the World Has Already Done  

India’s UDI delay is the exception globally, not the rule. Major markets have already implemented or are actively rolling out mandatory UDI:

The pattern is unmistakable: every major medical device market has either implemented UDI or is actively implementing it. India is among the last major markets without an enforced date — and that position is unlikely to persist much longer as CDSCO continues to align with IMDRF (International Medical Device Regulators Forum) global harmonization frameworks.

UDI Implementation: The 7-Step Process Importers Need to Understand  

When India’s UDI mandate activates, here is the implementation process importers will need to follow:

1. Device Classification  

Identify the classification of each medical device as per CDSCO rules (Class A, B, C, or D). UDI implementation will likely be phased by risk class — higher-risk devices first, as has been the pattern in every other market that has implemented UDI.

2. Select an Authorized UDI Issuing Agency  

Choose from the internationally recognized UDI issuing agencies: GS1 (most widely used), HIBCC, or ICCBBA. India is expected to authorize the same agencies recognized by US FDA and IMDRF. If your overseas manufacturer already has a UDI from these agencies for other markets, the DI may be directly applicable to India.

3. Assign the Device Identifier (DI)  

Generate a unique Device Identifier for each device model/configuration through the selected issuing agency. The DI is fixed for each product version — it identifies the manufacturer and the specific device model.

4. Assign the Production Identifier (PI)  

Include variable production data — batch/lot number, serial number, manufacturing date, and expiry date — in the PI component. This changes per production run and enables batch-specific traceability.

5. Apply UDI to Labels and Packaging  

Print the UDI on product labels and packaging in both HRI (human-readable) and AIDC (barcode/QR code) formats. For importers, this means coordinating with your overseas manufacturer to ensure UDI is applied at source before export to India — or applying it through label overlays for interim compliance.

6. Database Submission  

Upload UDI details (device identification data / device licence data including Product Code/DI, expiry date, lot number, and serial number) into the required CDSCO database — or maintain records as per CDSCO guidelines until the database infrastructure is operational. India’s future UDI database will likely integrate with the CDSCO online systems already established for device licensing / approval.

7. Maintain Records and Update Continuously  

Regularly update and maintain UDI data — including batch tracking records, distribution records, and complaint linkage by UDI. Post-market surveillance and adverse event reporting under MDR 2017 will increasingly reference UDI once the system is active.

What Importers Should Do in 2026 — Practical Action Plan  

1. Assess Your Current UDI Position  

Check whether your overseas manufacturers already hold UDI codes for your devices — from US FDA, EU MDR (EUDAMED), or other markets. If your manufacturer is already globally UDI-compliant, the Device Identifier (DI) may already be assigned. This is the single most efficient shortcut to India readiness.

2. Coordinate with Foreign Manufacturers Now  

The importer bears responsibility for ensuring devices entering India comply with all labelling requirements. UDI must be assigned at source — by the manufacturer. If your overseas manufacturer does not yet have UDI codes, initiate that conversation now. When India’s mandate activates, you will not have lead time to negotiate this with suppliers under deadline pressure.

3. Build Batch Traceability Records  

Even before UDI is mandatory in India, establishing strong batch tracking, distribution records, and complaint linkage by batch/serial number positions you for UDI compliance with minimal additional effort. These records are already required under MDR 2017’s post-market surveillance obligations.

4. Evaluate Your Internal Systems  

UDI requires structured data management — the ability to link device identifiers to supply chain records, distribution data, and adverse event reports. Assess whether your current ERP, inventory management, or compliance systems can accommodate UDI data fields. Upgrading now is far less disruptive than doing so under a compliance deadline.

5. Monitor CDSCO Notifications  

The new implementation date for Rule 46 will come through a MOHFW Gazette notification — the same mechanism used to announce the original delay. Subscribe to CDSCO’s notification feed and monitor the SUGAM portal for any new UDI-related circulars. When the notification comes, compliance timelines may be tight.

Common Misconceptions — Corrected  

UDI’s Broader Impact on India’s Medical Device Industry  

When India’s UDI mandate does take effect, the impact on the medical device ecosystem will be significant:

• Post-market surveillance will strengthen significantly — CDSCO will be able to link adverse event reports to specific device batches with precision currently not possible
• Recall management will become faster and more targeted — reducing patient exposure to defective devices and limiting the commercial scope of recalls for compliant manufacturers.
• Counterfeit and substandard devices will face higher barriers — genuine UDI-compliant devices will be verifiable; unregistered products will be more easily identified
• Digital compliance infrastructure will mature — UDI will accelerate India’s shift toward data-driven medical device regulation, aligning with CDSCO’s ongoing portal modernization through SUGAM and cdscomdonline.gov.in
• Companies with structured compliance systems will be better positioned — importers who have embedded traceability into their operations will navigate the UDI mandate with minimal disruption

The Bottom Line  

UDI is not fully mandatory in India in 2026 — but the legal foundation is in place, the global momentum is unmistakable, and CDSCO’s trajectory is clear. Rule 46 of MDR 2017 already provides for UDI requirements. The delay was administrative, not a policy reversal.

For medical device importers, the strategic choice is simple: prepare now at your own pace and timeline, or scramble when the notification comes with a deadline. Every major market — USA, EU, Japan, China, South Korea, Saudi Arabia — has already made UDI mandatory. India will follow.

The importers who begin UDI preparation in 2026 will have the smoothest transition. The ones who wait will face the same compressed timelines that caused compliance crises in every other market when mandates activated.

Need Help Preparing for UDI Compliance?  

We assist medical device importers and manufacturers with:

• UDI readiness assessment — current position against global and India requirements
• Overseas manufacturer coordination — ensuring UDI assignment at source
• Labelling and documentation alignment for Indian market
• Batch traceability systems review and gap analysis
• CDSCO regulatory planning — Rule 46 MDR 2017 compliance strategy
• Integration with existing CDSCO import licence compliance

Don’t wait for the mandate to start preparing.Talk to our regulatory team today →